MT2A and colorectal carcinoma: To further verify the expression of MT2A in CRC, TCGA data were used and analyzed by UALCAN online tool (http://ualcan.path.uab.edu), and significant downregulation of MT2A was observed in both colon cancer and rectal cancer (Fig. 1D, E).